نتایج جستجو برای: interferon β

تعداد نتایج: 243008  

2011
Shigeru Sasaki Tadao Ishida Minoru Toyota Akinobu Ota Hiromu Suzuki Akinori Takaoka Hiroshi Yasui Hiroyuki Yamamoto Hideyasu Takagi Masahiro Maeda Tsutomu Seito Masayuki Tsujisaki Yasuhisa Shinomura Kohzoh Imai

BACKGROUND Hepatocellular carcinoma (HCC) is the most commonly occurring primary liver cancer and ranks as the fifth most frequently occurring cancer, overall, and the third leading cause of cancer deaths, worldwide. At present, effective therapeutic options available for HCC are limited; consequently, the prognosis for these patients is poor. Our aim in the present study was to identify a nove...

Journal: :Iranian journal of immunology : IJI 2016
Keyvan Ghasami Fardin Faraji Masoud Fazeli Ali Ghazavi Ghasem Mosayebi

BACKGROUND Statins, widely used cholesterol-lowering agents, have also been demonstrated to have anti-inflammatory and immunomdulatory effects. OBJECTIVE To evaluate the effects of atorvastatin in combination with Interferon-β in the treatment of multiple sclerosis (MS) in a randomized controlled clinical trial. METHODS Multiple sclerosis patients were randomized independently, in a double ...

Arazmohammad Mirabi Davoud Shaker Farshideh Abedian, Saeid Abediankenari,

Background: Dendritic cells (DC) are a key regulator of the immune response, and interferon- beta (IFN-β) is considered an immunomodulatory molecule for DC. Objective: The purpose of this study was to evaluate the ability of IFN-β treated DC to induce cytokine secretion by CD4+ T cells. Methods: Dendritic cells were generated from blood monocytes with granulocyte-monocyte colony-stimulating fac...

2014
Luca Massacesi Irene Tramacere Salvatore Amoroso Mario A. Battaglia Maria Donata Benedetti Graziella Filippini Loredana La Mantia Anna Repice Alessandra Solari Gioacchino Tedeschi Clara Milanese

UNLABELLED For almost three decades in many countries azathioprine has been used to treat relapsing-remitting multiple sclerosis. However its efficacy was usually considered marginal and following approval of β interferons for this indication it was no longer recommended as first line treatment, even if presently no conclusive direct β interferon-azathioprine comparison exists. To compare azath...

Journal: :Journal of Immunology 2023

Abstract Lyme disease (LD) which is caused by the spirochete Borrelia burgdorferi (Bb) poses a global health threat. Bb infection induces type I IFN response that associated with arthritis and other symptoms. However, ligands, PAMPs, signaling pathways production are poorly characterized. Stimulator of Interferon Genes (STING) pathway an intracellular surveillance detects c-di-nucleotides (CDNs...

2007
Jaroslaw Smieja

This work presents a novel, two-scale model of viral infection evolution in a cell population taking into account immunological response based on Interferon-β. Infection dynamics is analyzed on a population level, using standard compartmental approach and on a intracellular level, describing biochemical processes taking place inside cells during infection. Additionally, an optimization problem ...

2014
Seong-Ji Han Heather J. Melichar Janine L. Coombes Shiao Wei Chan Anita A. Koshy John C. Boothroyd Gregory M. Barton Ellen A. Robey

The classic anti-viral cytokine interferon-β (IFN-β) can be induced during parasitic infection, but relatively little is know about the cell types and signaling pathways involved. Here we show that inflammatory monocytes (IMs), but not neutrophils, produce IFN-β in response to T. gondii infection. This difference correlated with the mode of parasite entry into host cells, with phagocytic uptake...

Journal: :Science 2014
Julie Lucifora Yuchen Xia Florian Reisinger Ke Zhang Daniela Stadler Xiaoming Cheng Martin F Sprinzl Herwig Koppensteiner Zuzanna Makowska Tassilo Volz Caroline Remouchamps Wen-Min Chou Wolfgang E Thasler Norbert Hüser David Durantel T Jake Liang Carsten Münk Markus H Heim Jeffrey L Browning Emmanuel Dejardin Maura Dandri Michael Schindler Mathias Heikenwalder Ulrike Protzer

Current antiviral agents can control but not eliminate hepatitis B virus (HBV), because HBV establishes a stable nuclear covalently closed circular DNA (cccDNA). Interferon-α treatment can clear HBV but is limited by systemic side effects. We describe how interferon-α can induce specific degradation of the nuclear viral DNA without hepatotoxicity and propose lymphotoxin-β receptor activation as...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید